Martina Maurelli (M Maurelli)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 50

Top Topics

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

American journal of clinical dermatology

Expert opinion on biological therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Luigi Gargiulo, Luciano Ibba, P Malagoli, F Amoruso, Anna Balato, F Bardazzi, M Burlando, C G Carrera, P Dapavo, Valentina Dini, Francesca Maria Gaiani, Giampiero Girolomoni, C Guarneri, C Lasagni, F Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, M Travaglini, Antonio Costanzo, A Narcisi
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology (2024)
Niccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, Anna Balato, Michela Ortoncelli, Martina Maurelli, Marco Galluzzo, Monica Munera Campos, Teofila Seremet, Lucia Di Nardo, Flaminia Antonelli, Giulia Coscarella, Curdin Conrad, Y José Manuel Carrascosa, Luca Bianchi, Giuseppe Argenziano, Simone Ribero, Giampiero Girolomoni, Angelo Valerio Marzano, Andrea Chiricozzi, Ketty Peris, null null
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, M B Guanti, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Andrea Chiricozzi, Niccolò Gori, Elena Ippoliti, Martina Maurelli, Flaminia Antonelli, Giulia Coscarella, Elisabetta Rizzo, Lucia Di Nardo, Giampiero Girolomoni, Ketty Peris
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Luigi Gargiulo, Luciano Ibba, F Piscazzi, F Amoruso, A Balato, Francesca Barei, Martina Bertello, A G Burroni, S Caccavale, S M Ferrucci, C Foti, Francesca Maria Gaiani, Giampiero Girolomoni, P Malagoli, Angelo Valerio Marzano, Martina Maurelli, Maddalena Napolitano, E Nettis, M Ortoncelli, C Patruno, E Pezzolo, Simone Ribero, P Romita, M T Rossi, I Zaza, Antonio Costanzo, A Narcisi
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher, Giampiero Girolomoni
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis. Journal of clinical medicine 12 (18) (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Advanced Glycation End Products and Psoriasis. Vaccines 11 (3) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy (2023)
Andrea Chiricozzi, Giacomo Dal Bello, Niccolò Gori, Lucia Di Nardo, Donatella Schena, Giacomo Caldarola, Martina Maurelli, Clara De Simone, Giampiero Girolomoni, Ketty Peris
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study. The Journal of dermatological treatment 34 (1) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Advanced Glycation End Products and Psoriasis. Vaccines 11 (3) (2023)
Martina Maurelli, Giampiero Girolomoni, Paolo Gisondi
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience. The Journal of dermatological treatment 34 (1) (2023)
Andrea Chiricozzi, Martina Maurelli, Laura Calabrese, Ketty Peris, Giampiero Girolomoni
Overview of Atopic Dermatitis in Different Ethnic Groups. Journal of clinical medicine 12 (7) (2023)
Luigi Gargiulo, Luciano Ibba, P Malagoli, F Amoruso, Giuseppe Argenziano, Anna Balato, F Bardazzi, M Burlando, C G Carrera, Giovanni Damiani, P Dapavo, Valentina Dini, G Fabbrocini, C Franchi, F M Gaiani, Giampiero Girolomoni, C Guarneri, C Lasagni, F Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, D Orsini, Francesca Sampogna, M Travaglini, M Valenti, Antonio Costanzo, A Narcisi
A Risankizumab Super Responder Profile Identified by Long-term Real-Life Observation- IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Paolo Gisondi, Francesco Bellinato, Martina Maurelli, Davide Geat, Alen Zabotti, Dennis McGonagle, Giampiero Girolomoni
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis. Psoriasis (Auckland, N.Z.) 12 (2022)
Paolo Gisondi, Davide Geat, Patrizio Armeni, Francesco Bellinato, Martina Maurelli, Giampiero Girolomoni
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis. Expert opinion on biological therapy (2022)
Paolo Gisondi, Martina Maurelli, Francesco Bellinato, Giampiero Girolomoni
Is risankizumab as needed administration a good option for patients with plaque psoriasis? Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Tailored biological treatment for patients with moderate-to-severe psoriasis. Expert review of clinical immunology (2022)
Andrea Chiricozzi, Niccolò Gori, Martina Maurelli, Paolo Gisondi, Giacomo Caldarola, Clara De Simone, Ketty Peris, Giampiero Girolomoni
Biological agents targeting interleukin-13 for atopic dermatitis. Expert opinion on biological therapy 22 (5) (2022)
Martina Maurelli, Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Simone Garcovich, Martina Maurelli, Paolo Gisondi, Ketty Peris, Gil Yosipovitch, Giampiero Girolomoni
Pruritus as a Distinctive Feature of Type 2 Inflammation. Vaccines 9 (3) (2021)
Francesco Bellinato, Paolo Gisondi, Martina Maurelli, Giampiero Girolomoni
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review. Dermatologic therapy 34 (2) (2021)
Francesco Bellinato, Martina Maurelli, Chiara Colato, Paolo Gisondi, Giampiero Girolomoni
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature. Clinical case reports 9 (6) (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products. Clinical and experimental dermatology (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. Journal of clinical medicine 10 (22) (2021)
Martina Maurelli, Francesco Bellinato, Giampiero Girolomoni
Adrenergic urticaria successfully treated with omalizumab. The Journal of dermatology 48 (11) (2021)
Giacomo Dal Bello, Martina Maurelli, Donatella Schena, Giampiero Girolomoni, Paolo Gisondi
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients. Dermatologic therapy 33 (6) (2020)
Martina Maurelli, Chiara Colato, Gianpaolo Tessari, Giampiero Girolomoni
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab. Dermatologic therapy 33 (6) (2020)
Martina Maurelli, Paolo Gisondi, E Danese, M Gelati, A Papagrigoraki, M Del Giglio, G Lippi, G Girolomoni
Psoriasin (S100A7) is increased in the serum of patients with moderate-to-severe psoriasis. The British journal of dermatology 182 (6) (2020)
Andrea Chiricozzi, Martina Maurelli, Ketty Peris, Giampiero Girolomoni
Targeting IL-4 for the Treatment of Atopic Dermatitis. ImmunoTargets and therapy 9 (2020)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
A systematic review of treatments for pityriasis lichenoides. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (11) (2019)
Francesco Bellinato, Martina Maurelli, C Colato, R Balter, G Girolomoni, D Schena
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. The British journal of dermatology 180 (4) (2018)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Kyrle's disease effectively treated with oral isotretinoin. The Journal of dermatological treatment 29 (6) (2018)
Martina Maurelli, Roberto Bergamaschi, Ambra Antonini, Maria Concetta Fargnoli, Elisa Puma, Giulia Mallucci, Rocco Totaro, Giampiero Girolomoni
Interferon-beta injection site reactions in patients with multiple sclerosis. The Journal of dermatological treatment 29 (8) (2018)
Martina Maurelli, Chiara Colato, Giampiero Girolomoni, Paolo Gisondi
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin. The Journal of dermatology 44 (12) (2017)